Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand

Journal of Biological Chemistry

Volumn 288, Issue 16, 2013, Pages 10967-10972

  Kanaoka, Yoshihide ^a   Maekawa, Akiko ^a   Austen, K Frank ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLAMMATORY DISEASE; THERAPEUTIC TARGETS; VASCULAR PERMEABILITY;

BIOCHEMISTRY; BIOLOGY;

MAMMALS;

COMPLEMENTARY DNA; CYSTEINE; DICARBOXYLIC ACID; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 99; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR; PURINERGIC P2Y RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; EAR EDEMA; FEMALE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REPORTER GENE; TRANSACTIVATION; WILD TYPE;

ANIMALS; CAPILLARY PERMEABILITY; INFLAMMATION; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LIGANDS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, LEUKOTRIENE;

MUS;

EID: 84876578638     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.C113.453704     Document Type: Article

References (35)

1. Peters-Golden, M., and Henderson, W. R., Jr. (2007) Leukotrienes. N. Engl. J. Med. 357, 1841-1854.
2. Austen, K. F., Maekawa, A., Kanaoka, Y., and Boyce, J. A. (2009) The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications. J. Allergy Clin. Immunol. 124, 406-414.
3. Lynch, K. R., O'Neill, G. P., Liu, Q., Im, D. S., Sawyer, N., Metters, K. M., Coulombe, N., Abramovitz, M., Figueroa, D. J., Zeng, Z., Connolly, B. M., Bai, C., Austin, C. P., Chateauneuf, A., Stocco, R., Greig, G. M., Kargman, S., Hooks, S. B., Hosfield, E., Williams, D. L., Jr., Ford-Hutchinson, A. W., Caskey, C. T., and Evans, J. F. (1999) Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399, 789-793.
4. Heise, C. E., O'Dowd, B. F., Figueroa, D. J., Sawyer, N., Nguyen, T., Im, D. S., Stocco, R., Bellefeuille, J. N., Abramovitz, M., Cheng, R., Williams, D. L., Jr., Zeng, Z., Liu, Q., Ma, L., Clements, M. K., Coulombe, N., Liu, Y., Austin, C. P., George, S. R., O'Neill, G. P., Metters, K. M., Lynch, K. R., and Evans, J. F. (2000) Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 275, 30531-30536.
5. Leff, J. A., Busse, W. W., Pearlman, D., Bronsky, E. A., Kemp, J., Hendeles, L., Dockhorn, R., Kundu, S., Zhang, J., Seidenberg, B. C., and Reiss, T. F. (1998) Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N. Engl. J. Med. 339, 147-152.
6. Dahlén, S. E., Malmström, K., Nizankowska, E., Dahlén, B., Kuna, P., Kowalski, M., Lumry, W. R., Picado, C., Stevenson, D. D., Bousquet, J., Pauwels, R., Holgate, S. T., Shahane, A., Zhang, J., Reiss, T. F., and Szczeklik, A. (2002) Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 165, 9-14.
7. Lam, S., Chan, H., LeRiche, J. C., Chan-Yeung, M., and Salari, H. (1988) Release of leukotrienes in patients with bronchial asthma. J. Allergy Clin. Immunol. 81, 711-717.
8. Zarini, S., Gijón, M. A., Ransome, A. E., Murphy, R. C., and Sala, A. (2009) Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation. Proc. Natl. Acad. Sci. U.S.A. 106, 8296-8301.
9. Lee, T. H., Austen, K. F., Corey, E. J., and Drazen, J. M. (1984) Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors. Proc. Natl. Acad. Sci. U.S.A. 81, 4922-4925.
10. Jacques, C. A., Spur, B. W., Johnson, M., and Lee, T. H. (1991) The mechanism of LTE4-induced histamine hyperresponsiveness in guinea-pig tracheal and human bronchial smooth muscle, in vitro. Br. J. Pharmacol. 104, 859-866.
11. Lewis, R. A., Drazen, J. M., Austen, K. F., Clark, D. A., and Corey, E. J. (1980) Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRSA). Importance of the 11-cis-geometry for biological activity. Biochem. Biophys. Res. Commun. 96, 271-277.
12. Soter, N. A., Lewis, R. A., Corey, E. J., and Austen, K. F. (1983) Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J. Invest. Dermatol. 80, 115-119.
13. Laitinen, L. A., Laitinen, A., Haahtela, T., Vilkka, V., Spur, B. W., and Lee, T. H. (1993) Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet 341, 989-990.
14. Gauvreau, G. M., Parameswaran, K. N., Watson, R. M., and O'Byrne, P. M. (2001) Inhaled leukotriene E4, but not leukotriene D4, increased airway inflammatory cells in subjects with atopic asthma. Am. J. Respir. Crit. Care Med. 164, 1495-1500.
15. Bäck, M., Dahlén, S. E., Drazen, J. M., Evans, J. F., Serhan, C. N., Shimizu, T., Yokomizo, T., and Rovati, G. E. (2011) International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions. Pharmacol. Rev. 63, 539-584.
16. Maekawa, A., Kanaoka, Y., Lam, B. K., and Austen, K. F. (2001) Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing. Proc. Natl. Acad. Sci. U.S.A. 98, 2256-2261.
17. Hui, Y., Yang, G., Galczenski, H., Figueroa, D. J., Austin, C. P., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., and Funk, C. D. (2001) The murine cysteinyl leukotriene 2 (CysLT2) receptor: cDNA and genomic cloning, alternative splicing, and in vitro characterization. J. Biol. Chem. 276, 47489-47495.
18. Ogasawara, H., Ishii, S., Yokomizo, T., Kakinuma, T., Komine, M., Tamaki, K., Shimizu, T., and Izumi, T. (2002) Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distribution. J. Biol. Chem. 277, 18763-18768.
19. Maekawa, A., Kanaoka, Y., Xing, W., and Austen, K. F. (2008) Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors. Proc. Natl. Acad. Sci. U.S.A. 105, 16695-16700.
20. Malmstrom, K., Rodriguez-Gomez, G., Guerra, J., Villaran, C., Piñeiro, A., Wei, L. X., Seidenberg, B. C., and Reiss, T. F. (1999) Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann. Intern. Med. 130, 487-495.
21. Szefler, S. J., Phillips, B. R., Martinez, F. D., Chinchilli, V. M., Lemanske, R. F., Strunk, R. C., Zeiger, R. S., Larsen, G., Spahn, J. D., Bacharier, L. B., Bloomberg, G. R., Guilbert, T. W., Heldt, G., Morgan, W. J., Moss, M. H., Sorkness, C. A., and Taussig, L. M. (2005) Characterization of withinsubject responses to fluticasone and montelukast in childhood asthma. J. Allergy Clin. Immunol. 115, 233-242.
22. Drazen, J. M., O'Brien, J., Sparrow, D., Weiss, S. T., Martins, M. A., Israel, E., and Fanta, C. H. (1992) Recovery of leukotriene E4 from the urine of patients with airway obstruction. Am. Rev. Respir. Dis. 146, 104-108.
23. He, W., Miao, F. J., Lin, D. C., Schwandner, R. T., Wang, Z., Gao, J., Chen, J. L., Tian, H., and Ling, L. (2004) Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429, 188-193.
24. Lam, B. K., Owen, W. F., Jr., Austen, K. F., and Soberman, R. J. (1989) The identification of a distinct export step following the biosynthesis of leukotriene C4 by human eosinophils. J. Biol. Chem. 264, 12885-12889.
25. Schöneberg, T., Hermsdorf, T., Engemaier, E., Engel, K., Liebscher, I., Thor, D., Zierau, K., Römpler, H., and Schulz, A. (2007) Structural and functional evolution of the P2Y12-like receptor group. Purinergic Signal. 3, 255-268.
26. Wittenberger, T., Hellebrand, S., Munck, A., Kreienkamp, H. J., Schaller, H. C., and Hampe, W. (2002) GPR99, a new G protein-coupled receptor with homology to a new subgroup of nucleotide receptors.BMCGenomics 3, 17.
27. Inbe, H., Watanabe, S., Miyawaki, M., Tanabe, E., and Encinas, J. A. (2004) Identification and characterization of a cell-surface receptor, P2Y15, for AMP and adenosine. J. Biol. Chem. 279, 19790-19799.
28. Kamohara, M., Takasaki, J., Matsumoto, M., Matsumoto, S. i., Saito, T., Soga, T., Matsushime, H., and Furuichi, K. (2001) Functional characterization of cysteinyl leukotriene CysLT2 receptor on human coronary artery smooth muscle cells. Biochem. Biophys. Res. Commun. 287, 1088-1092.
29. Shirasaki, H., Kanaizumi, E., Watanabe, K., Matsui, T., Sato, J., Narita, S., Rautiainen, M., and Himi, T. (2002) Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa. Clin. Exp. Allergy 32, 1007-1012.
30. Sala, A., Voelkel, N., Maclouf, J., and Murphy, R. C. (1990) Leukotriene E4 elimination and metabolism in normal human subjects. J. Biol. Chem. 265, 21771-21778.
31. Arm, J. P., O'Hickey, S. P., Hawksworth, R. J., Fong, C. Y., Crea, A. E., Spur, B. W., and Lee, T. H. (1990) Asthmatic airways have a disproportionate hyperresponsiveness to LTE4, as compared with normal airways, but not to LTC4, LTD4, methacholine, and histamine. Am. Rev. Respir. Dis. 142, 1112-1118.
32. Davidson, A. B., Lee, T. H., Scanlon, P. D., Solway, J., McFadden, E. R., Jr., Ingram, R. H., Jr., Corey, E. J., Austen, K. F., and Drazen, J. M. (1987) Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects. Am. Rev. Respir. Dis. 135, 333-337.
33. Christie, P. E., Hawksworth, R., Spur, B. W., and Lee, T. H. (1992) Effect of indomethacin on leukotriene4-induced histamine hyperresponsiveness in asthmatic subjects. Am. Rev. Respir. Dis. 146, 1506-1510.
34. Christie, P. E., Tagari, P., Ford-Hutchinson, A. W., Black, C., Markendorf, A., Schmitz-Schumann, M., and Lee, T. H. (1992) Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects. Am. Rev. Respir. Dis. 146, 1531-1534.
35. Park, J. S., Jang, A. S., Park, S. W., Lee, Y. M., Uh, S. T., Kim, Y. H., Cha, J. Y., Park, S. M., and Park, C. S. (2010) Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics. Allergy Asthma Immunol. Res. 2, 48-54.